Clinical Trial: The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Lung Neoplasms
Study Type: INTERVENTIONAL
Official Title: A Prospective, Two Cohort, Multicenter Phase II Clinical Study of Envafolimab Combined With Concurrent Chemoradiotherapy and Immune Maintenance Therapy For Limited Stage Small Cell Lung Cancer
Brief Summary:
To evaluate the efficacy and safety of envafolimab combined with concurrent chemoradiotherapy in limited stage small cell lung cancer.
Read more